SULINDAC METABOLISM - THE IMPORTANCE OF AN INTACT COLON

被引：51

作者：

STRONG, HA ^{[1
]}

WARNER, NJ ^{[1
]}

RENWICK, AG ^{[1
]}

GEORGE, CF ^{[1
]}

机构：

[1] UNIV SOUTHAMPTON,FAC MED,CLIN PHARMACOL GRP,MED & BIOL SCI BLDG,BASSETT CRESCENT E,SOUTHAMPTON SO9 3TU,HANTS,ENGLAND

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1985年 / 38卷 / 04期

关键词：

D O I：

10.1038/clpt.1985.192

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：387 / 393

页数：7

共 18 条

[1] SULINDAC - REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC EFFICACY IN RHEUMATIC DISEASES [J].

BROGDEN, RN ;

HEEL, RC ;

SPEIGHT, TM ;

AVERY, GS .

DRUGS, 1978, 16 (02) :97-114

[2] BILIARY-SECRETION OF SULINDAC AND METABOLITES IN MAN [J].

DOBRINSKA, MR ;

FURST, DE ;

SPIEGEL, T ;

VINCEK, WC ;

TOMPKINS, R ;

DUGGAN, DE ;

DAVIES, RO ;

PAULUS, HE .

BIOPHARMACEUTICS & DRUG DISPOSITION, 1983, 4 (04) :347-358

[3]

Drasar B. S., 1974, HUMAN INTESTINAL FLO

[4]

DUGGAN DE, 1977, J PHARMACOL EXP THER, V201, P8

[5] COMPARATIVE DISPOSITION OF SULINDAC AND METABOLITES IN 5 SPECIES [J].

DUGGAN, DE ;

HOOKE, KF ;

NOLL, RM ;

HUCKER, HB ;

VANARMAN, CG .

BIOCHEMICAL PHARMACOLOGY, 1978, 27 (19) :2311-2320

[6] SULINDAC - THERAPEUTIC IMPLICATIONS OF THE PRODRUG PHARMACOPHORE EQUILIBRIUM [J].

DUGGAN, DE .

DRUG METABOLISM REVIEWS, 1981, 12 (02) :325-337

[7]

DUGGAN DE, 1980, DRUG METAB DISPOS, V8, P241

[8]

DUGGAN DE, 1977, CLIN PHARMACOL THER, V21, P326

[9] ENTEROHEPATIC CIRCULATION OF SULINDAC AND METABOLITES [J].

DUJOVNE, CA ;

PITTERMAN, A ;

VINCEK, WC ;

DOBRINSKA, MR ;

DAVIES, RO ;

DUGGAN, DE .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 33 (02) :172-177

[10] IBUPROFEN AND SULINDAC KINETICS IN ALCOHOLIC LIVER-DISEASE [J].

JUHL, RP ;

VANTHIEL, DH ;

DITTERT, LW ;

ALBERT, KS ;

SMITH, RB .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1983, 34 (01) :104-109

← 1 2 →